A REVIEW OF SODIUM PENTOBARBITAL (NAP)

Contraindicated (one)pentobarbital will lessen the extent or effect of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers may end up in diminished serum concentrations and loss of antimalarial efficacyRoutine forming: Barbiturates could be habit forming. Tolerance,